Dare bioscience press release

WebMar 1, 2024 · SAN DIEGO, March 01, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a leader in women’s health innovation, today announced that Sabrina Martucci Johnson, the company’s President and CEO, will present at the 35 th Annual Roth Conference, being held March 12-14, 2024 in Laguna Niguel, CA. WebApr 1, 2024 · SAN DIEGO, April 01, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced it received a Notice of Award of $730,722 in a grant supporting the Ovaprene® postcoital test (PCT) clinical study research from the Eunice Kennedy Shriver National Institute of Child Health …

2024-03-30 NDAQ:DARE Press Release Dare Bioscience Inc.

WebMar 23, 2024 · SAN DIEGO, March 23, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a leader in women’s health innovation, today announced that it will host a conference call and live webcast... WebJun 30, 2024 · Press Release Daré Bioscience Reports Second Quarter 2024 Financial Results and Provides a Company Update 08-09-2024 at 8:00 AM EDT PDF Version June 30, 2024: $32.1 million in cash and cash equivalents July 2024: approximately $18.0 million in cash received subsequent to quarter-end: chive university https://bigalstexasrubs.com

Press Releases Daré Bioscience

WebMar 30, 2024 · 10-K: DARE BIOSCIENCE, INC. Published: March 30, 2024 at 4:05 p.m. ET. The MarketWatch News Department was not involved in the creation of this content. (EDGAR Online via COMTEX) -- ITEM 7 ... WebJul 26, 2024 · SAN DIEGO, July 26, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that David Friend, PhD, the company’s Chief Scientific Officer, will present data from preclinical and clinical studies related to DARE-BV1 at the 2024 Controlled Release Society (CRS) … WebMar 30, 2024 · SAN DIEGO, March 30, 2024 (GLOBE NEWSWIRE) -- Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today reported financial results for the year ended December 31,... grass in little alchemy 2

About Daré Bioscience

Category:Daré Bioscience Announces the Presentation of DARE-BVFREE …

Tags:Dare bioscience press release

Dare bioscience press release

Scrip Asks…What Does 2024 Hold For Biopharma? Part 8: …

WebApr 28, 2024 · SAN DIEGO, April 28, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc.(NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Martucci Johnson, President and Chief Executive Officer, will participate in a panel discussion during the Infectious Disease Virtual Conference presented by Maxim Group … WebOct 28, 2024 · SAN DIEGO, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, and Strategic Science & Technologies, LLC (SST), a Cambridge, MA based novel topical drug delivery company, today announced a poster presentation at the Sexual Medicine Society of North America …

Dare bioscience press release

Did you know?

WebMar 17, 2024 · Scrip Asks…What Does 2024 Hold For Biopharma? Part 8: Therapeutic Area Advances (Subscription required) WebMar 30, 2024 · Daré Bioscience, Inc. filed its 10-K on Mar 30, 2024 for the period ending Dec 31, 2024. ... Press Releases. Security Transactions. Earnings reports. New markets. New products. Corporate strategies. ... Dare Bioscience, Inc. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K) ...

WebMar 30, 2024 · Dare Bioscience press release ( NASDAQ: DARE ): FY GAAP EPS of -$0.37 misses by $0.07. Revenue of $10M in-line. Cash and cash equivalents: $34.7 million at December 31, 2024, compared to $51.7... WebMar 31, 2024 · Press Release Organon Enters into Global License Agreement to Commercialize Daré Bioscience’s XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis (BV) 03-31-2024 at 7:00 AM EDT PDF Version An estimated 21 million American women experience …

WebJul 23, 2024 · We are accelerating innovation in women’s health. At Daré, we believe women’s health is an important therapeutic area that deserves dramatically increased … WebJan 9, 2024 · Daré Bioscience Announces Publication in Menopause: The Journal of The North American Menopause Society of Data from Phase 1 Trial of DARE-HRT1 that … This section contains both current and archived webcasts and presentations of … The Investor Relations website contains information about Daré Bioscience's …

WebDec 31, 2024 · SAN DIEGO, March 23, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Thursday, March 30, 2024, to review its financial results for the year ended December 31, 2024 and to provide …

WebPress Release. Daré Bioscience Announces Publication in Menopause: The Journal of The North American Menopause Society of Data from Phase 1 Trial of DARE-HRT1 that Support the Potential of DARE ... grass in maoriWebFeb 13, 2024 · SAN DIEGO, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE) today announced the pricing of its previously announced underwritten public offering of 5.0 million shares of its common stock and warrants to purchase up to 3.5 million shares of its common stock. grass in lafayette laWebJan 9, 2024 · Daré Bioscience Announces Publication in Menopause: The Journal of The North American Menopause Society of Data from Phase 1 Trial of DARE-HRT1 that … grass in mathWebMar 29, 2024 · Scrip Asks…What Does 2024 Hold For Biopharma? Part 10: Diversity, Equity And Inclusion (Subscription required) chive user offs2WebApr 26, 2024 · SAN DIEGO, April 26, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced that data from the DARE-BVFREE Phase 3 study of DARE-BV1, a thermosetting vaginal gel for the treatment of bacterial vaginosis, will be presented at the 2024 American College of … chive urbanWebDec 7, 2024 · SAN DIEGO, Dec. 07, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that the U.S. Food and Drug Administration (FDA)... chive waistchive vegetable